TearSolutions, Inc., 2025-11-10
An SEC Form D private-offering notice from Charlottesville, VA, a $517,000 filer-stated offering target in Biotech. Filed 2025-11-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
TearSolutions develops Lacripep, a novel peptide therapy for ocular surface disease including dry eye and Sjogren's syndrome related dry eye.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SPECTER OPS, INC., 2025-11-26, $30M, Alexandria, VA
- EPALEX Corp, 2025-11-10, $3.2M, Mountain View, CA
- Tellius, Inc., 2025-11-25, $3.1M, Herndon, VA
- ARTELO BIOSCIENCES, INC., 2025-11-10, $3.7M, Solana Beach, CA
- Revo Zero Corp, 2025-11-14, $2M, Herndon, VA
- TuHURA Biosciences, Inc./NV, 2025-11-10, $3M, Tampa, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.